TPG-backed TE Asia to expand specialty healthcare in Singapore, Malaysia and Indonesia
Private group will invest a further US$90m over the next 18 months in these countries to set up doctor-owned specialty centres and hospitals for oncology, cardiology and orthopaedics
Add BT as a preferred source
Singapore
AFTER investing US$170 million in its South-east Asia portfolio of specialty centres and hospitals focusing on oncology, cardiovascular and orthopaedics, TE Asia Healthcare Partners will be injecting a further US$90 million over the next 18 months to increase its regional footprint in Singapore, Malaysia and Indonesia.
In an interview with The Business Times, Eng Aik Meng, group chief executive officer of the Singapore-based private specialty healthcare group backed by US private equity giant TPG Capital, said the Covid-19 had not significantly affected its strategic timeline.
TRENDING NOW
China narrows AI gap with US as open-source shift could hit valuations: George Yeo
‘So little’?: Why critics of Temasek’s 10.5% returns in a bull run are getting it wrong
Samsung, SK Hynix and leveraged ETFs drive 70% of Korea trading, drawing criticism
Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects
